In a variety of tumors with different tissue origins, KDM1A has been reported to regulate stemness and drug resistance, such as hepatocellular carcinoma 10, 41, leukemia 42, and breast cancer 43, though the exact mechanisms are diverse. Here, KDM1A is linked to breast carcinoma.